ArticleScientific reports2026
Enhancing esophageal cancer detection using a deep learning framework and a novel spectrum-aided vision enhancer for virtual narrow band imaging.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Esophageal cancer is a highly aggressive malignancy where early detection is critical for survival. However, early-stage lesions typically present subtle mucosal changes that are difficult to identify using standard White Light Imaging (WLI), and hardware-based Narrow Band Imaging (NBI) is not universally available. In this study, we propose a novel image processing algorithm termed the Spectrum-Aided Vision Enhancer (SAVE) to address these challenges in computer-aided diagnosis (CAD). Leveraging hyperspectral data principles, SAVE transforms standard WLI endoscopic images into enhanced, NBI-like representations, significantly improving mucosal contrast and lesion visibility without requiring additional hardware. To validate the efficacy of this approach for medical image analysis, we utilized a dataset of Squamous Cell Carcinoma (SCC) and dysplasia. We conducted a comprehensive comparative analysis using five state-of-the-art deep learning models: YOLOv8, InceptionV3, Inception-ResNet-V2, ConvNeXt-V2, and MobileNetV2. Experimental results demonstrate that models trained on SAVE-enhanced images significantly outperform those trained on traditional WLI in both classification and detection tasks. This study presents a cost-effective, software-driven solution that integrates advanced image processing with deep learning, offering a robust tool for the automated screening of esophageal malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.